Kristie L. Kahl

While some immunotherapy drugs have been approved for the treatment of renal cell carcinoma (RCC), researchers are still investigating how to best harness the immune system for this patient population, explained Dr. Vivek Narayan. “I think with novel immune therapy development in kidney cancer, it appears that we’re really building on the effective backbone of PD1/CTLA4 inhibition,” Narayan, assistant professor of medicine (hematology-oncology) at the Hospital of the University of Pennsylvani…

In part five of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, offered alternative, fun options to wigs for patients with cancer who have experienced hair loss from treatment. “If at any time during your journey, you’re open to change, this is the time in your life that you want to take that chance,” Hernandez-Salas said, adding that her everyday wig is similar to the hair she has had her en…

In part four of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, discussed how to wash and care for a wig worn by patients with cancer experiencing treatment-related hair loss. Summary: 00:04 – Shampooing a wig If a patient wears one wig every day, they should shampoo it every two to three weeks; however, this could be dependent on perspiration and wear. For example, Daniela Hernandez-Salas…

In part two of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, demonstrated how to put on and adjust a wig for patients who are undergoing treatment and experiencing hair loss as a result. “When I first started wearing the wig, this was probably the most difficult for me to get thing to get used to,” Hernandez-Salas explained. She overviewed the proper placement of a wig and how to adjust…

In part one of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, spoke about her journey with hair loss and, based on her experience, offered tips for haircare and hair loss. In particular, she overviewed wigs and head coverings, as well as way to deal with hair loss and regrowth, while also offering things to avoid along the way. Summary: 00:36 – Wigs and head coverings for patients with c…

In part three of CURE’s “Confidently You: Choosing and Styling Wigs that Look and Feel Right” webinar, Daniela Hernandez-Salas, a Look Good Feel Better volunteer, offered ways for patients with cancer to style their wigs following hair loss from treatment. “So the wonderful thing about wigs is that you really don’t ever have to style wigs that much,” Hernandez-Salas explained. “wigs have memory. So even after you shampoo them, they come right back to (their original style).” In particu…

In part one of CURE’s “Radiance Unveiled: Skincare and Makeup Strategies Throughout Breast Cancer Treatment” webinar, Rudy Miles, a 10-year Look Good Feel Better volunteer and national trainer, and Olivia Summer Hutcherson, a three-time survivor and thriver, demonstrated makeup techniques and application of concealer, foundation, powder and blush. “The reason you want to think of makeup for this section is think of it more as a tool. So usually, we wear makeup for the glamour of it, which…

In part one of CURE’s “Radiance Unveiled: Skincare and Makeup Strategies Throughout Breast Cancer Treatment” webinar, Rudy Miles, a 10-year Look Good Feel Better volunteer and national trainer, and Olivia Summer Hutcherson, a three-time survivor and thriver, discussed skincare during cancer treatment to assist patients in their daily routine, discussing what products they should use and what to avoid. In this segment, Miles focused on a daily routine patients can follow as part of their s…

In part one of CURE’s “Radiance Unveiled: Skincare and Makeup Strategies Throughout Breast Cancer Treatment” webinar, Rudy Miles, a 10-year Look Good Feel Better volunteer and national trainer, and Olivia Summer Hutcherson, a three-time survivor and thriver, offered techniques in applying lip care. “We had a firsthand testimonial that sometimes the appearance, really the side effects of the skin, is dryness. And believe it or not, that also affects the lips,” Miles said. In addition, M…

Patients with hormone receptor-positive HER2-low or HER2-negative metastatic breast cancer tended to have improved progression-free survival (PFS; time from treatment until disease worsening or death) when being treated with datopotamab deruxtecan (Dato-DXd), compared to those being treated with chemotherapy, according to findings from the phase 3 TROPION-Breast-1 clinical trial. The study findings were presented at the 2023 ESMO Congress. “Overall results support Dato-DXd as a potential new…

The addition of Keytruda (pembrolizumab) to Xtandi (enzalutamide) showed no improvements in radiographic progression-free survival (rPFS; time from treatment until new cancer lesions are seen on scans) and overall survival (OS; time from treatment until death from any cause), when comparing Xtandi alone in patients with metastatic castration-resistant prostate cancer (mCRPC), according to data from the KEYNOTE-641 study presented at the ESMO Congress 2023. As a result, the primary end points…

Neoadjuvant (pre-surgical) treatment with Opdivo (nivolumab) plus chemotherapy followed by surgery and adjuvant (treatment administered following the main treatment) Opdivo significantly improved event-free survival (EFS, the time a patient lives without complications from the disease), compared with placebo plus chemotherapy, in patients with previously untreated resectable (able to be removed via surgery) stage 2 to 3B non-small cell lung cancer (NSCLC), according to data from the phase 3 Ch…

Two years of Verzenio (abemaciclib) plus endocrine therapy (ET) in some patients with breast cancer continued to reduce the risk for invasive disease- (IDFS) and distant relapse-free survival (DRFS), according to findings from a recent trial. Specifically, patients with hormone receptor (HR)-positive, HER2-negative, node-positive, high-risk early breast cancer had reduced risk for IDFS and DRFS when they received the treatment combination of Verzenio and ET for two years. Verzenio is a type…

In part two of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, discussed lower participation rates in clinical trials among Black women, and factors, like lack of education around breast cancer and…

In part one of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, discussed the differences that women of color experience throughout their breast cancer journey, highlighting the need for more divers…

In part five of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, discussed way patients can be empowered to seek out and receive the best care for their treatment. “I’m impatient about finding an…

In part four of CURE’s “Breaking Barriers: Addressing Women of Color Underrepresentation in Clinical Trials” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, discussed common misperceptions about clinical trials. However, they also highlighted the unknown benefits to being on a trial, in…

In part three of CURE’s “Mind Over Matter: Cultivating a Resilient Mindset During Breast Cancer Treatment” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, defined what mental resilience means to them throughout one’s breast cancer journey. “Resilience for me is living in my truth and no…

In part four of CURE’s “Mind Over Matter: Cultivating a Resilient Mindset During Breast Cancer Treatment” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, offered advice on how patients with breast cancer can be aware of and seek support for their mental and emotional health during their br…

In part five of CURE’s “Mind Over Matter: Cultivating a Resilient Mindset During Breast Cancer Treatment” webinar, Ricki Fairley, CEO of TOUCH, The Black Breast Cancer Alliance; Hayley Brown, director of partnerships and programs at TOUCH, The Black Breast Cancer Alliance; and Michelle Anderson-Benjamin, CEO and founder of The Fearless Warrior Organization, discuss ways others showed up for them, helping them to delegate tasks and take things off of their plates during their breast cancer jo…